Pathologically and Biologically Distinct Types of Epithelium in Intraductal Papillary Mucinous Neoplasms: Delineation of an “Intestinal” Pathway of Carcinogenesis in the Pancreas
暂无分享,去创建一个
Olca Basturk | David S Klimstra | F. Sarkar | R. Hruban | C. Iacobuzio-Donahue | O. Basturk | D. Klimstra | N. Adsay | Ralph H Hruban | Fazlul H Sarkar | Christine Iacobuzio-Donahue | N Volkan Adsay | K. Merati | E. Levi | Jeanette D. Cheng | Kambiz Merati | Edi Levi | Jeanette D Cheng | N. V. Adsay | Kambiz Merati
[1] Hiroshi Yamamoto,et al. Homeodomain protein CDX2 regulates goblet-specific MUC2 gene expression. , 2003, Biochemical and biophysical research communications.
[2] Isabelle Duluc,et al. Key Role of the Cdx2 Homeobox Gene in Extracellular Matrix–mediated Intestinal Cell Differentiation , 1997, The Journal of cell biology.
[3] A. Mccarthy. Development , 1996, Current Opinion in Neurobiology.
[4] L. Yin,et al. The Epidermal Growth Factor Receptor Regulates Interaction of the Human DF3/MUC1 Carcinoma Antigen with c-Src and β-Catenin* , 2001, The Journal of Biological Chemistry.
[5] C. Moskaluk,et al. Cdx2 as a Marker of Epithelial Intestinal Differentiation in the Esophagus , 2003, The American journal of surgical pathology.
[6] F. Sarkar,et al. The Dichotomy in the Preinvasive Neoplasia to Invasive Carcinoma Sequence in the Pancreas: Differential Expression of MUC1 and MUC2 Supports the Existence of Two Separate Pathways of Carcinogenesis , 2002, Modern Pathology.
[7] D. Longnecker. Observations on the etiology and pathogenesis of intraductal papillary-mucinous neoplasms of the pancreas. , 1998, Hepato-gastroenterology.
[8] T. Mattfeldt,et al. Intraductal papillary mucinous tumor of the pancreas. , 1999, American journal of surgery.
[9] D. Silberg,et al. Expression of intestine‐specific transcription factors, CDX1 and CDX2, in intestinal metaplasia and gastric carcinomas , 2003, The Journal of pathology.
[10] A. Sonnenberg,et al. Episialin (MUC1) overexpression inhibits integrin-mediated cell adhesion to extracellular matrix components , 1995, The Journal of cell biology.
[11] A. Scarpa,et al. Intraductal papillary-mucinous tumours represent a distinct group of pancreatic neoplasms: an investigation of tumour cell differentiation and K-ras, p53 and c-erbB-2 abnormalities in 26 patients , 2004, Virchows Archiv.
[12] I Duluc,et al. The Cdx2 homeobox gene has a tumour suppressor function in the distal colon in addition to a homeotic role during gut development , 2003, Gut.
[13] J. Devière,et al. Intraductal papillary and mucinous tumors of the pancreas: accuracy of preoperative computed tomography, endoscopic retrograde pancreatography and endoscopic ultrasonography, and long-term outcome in a large surgical series. , 1998, Gastrointestinal endoscopy.
[14] G. Gores,et al. Increased expression of cyclooxygenase‐2 in human pancreatic neoplasms and potential for chemoprevention by cyclooxygenase inhibitors , 2002, Cancer.
[15] S. Takao,et al. Gene expression of gastric type mucin (MUC5AC) in pancreatic tumors: Its relationship with the biological behavior of the tumor , 1999, Pathology international.
[16] J. Lüttges,et al. The Mucin Profile of Noninvasive and Invasive Mucinous Cystic Neoplasms of the Pancreas , 2002, The American journal of surgical pathology.
[17] Y. Yuasa. Control of gut differentiation and intestinal-type gastric carcinogenesis , 2003, Nature Reviews Cancer.
[18] H. Seno,et al. CDX2 expression in the stomach with intestinal metaplasia and intestinal-type cancer: Prognostic implications. , 2002, International journal of oncology.
[19] G. Deng,et al. Methylation status of promoters and expression of MUC2 and MUC5AC mucins in pancreatic cancer cells. , 2003, International journal of oncology.
[20] S. Takao,et al. MUC‐1 mucin expression in invasive areas of intraductal papillary mucinous tumors of the pancreas , 1998, Pathology international.
[21] K. Sugano,et al. Conversion of gastric mucosa to intestinal metaplasia in Cdx2-expressing transgenic mice. , 2002, Biochemical and biophysical research communications.
[22] Massimo Loda,et al. Silencing of CDX2 Expression in Colon Cancer via a Dominant Repression Pathway* , 2003, Journal of Biological Chemistry.
[23] A. Yanagisawa,et al. Ductectatic‐type Mucinous Cystadenoma and Cystadenocarcinoma of the Human Pancreas: A Novel Clinicopathological Entity , 1993, Japanese journal of cancer research : Gann.
[24] G. Zamboni,et al. The Immunohistochemical Mucin Expression Pattern Distinguishes Different Types of Intraductal Papillary Mucinous Neoplasms of the Pancreas and Determines Their Relationship to Mucinous Noncystic Carcinoma and Ductal Adenocarcinoma , 2001, The American journal of surgical pathology.
[25] Kan Yang,et al. Colorectal Cancer in Mice Genetically Deficient in the Mucin Muc2 , 2002, Science.
[26] R. Hawes,et al. Primary cystic neoplasms of the pancreas: neoplastic disorders of emerging importance—current state-of-the-art and unanswered questions , 2003, Journal of Gastrointestinal Surgery.
[27] K. Kaestner,et al. Cdx2 ectopic expression induces gastric intestinal metaplasia in transgenic mice. , 2002, Gastroenterology.
[28] T. Furukawa,et al. Intraductal papillary mucinous tumors of the pancreas comprise 2 clinical subtypes: differences in clinical characteristics and surgical management. , 1999, Archives of surgery.
[29] N. Adsay,et al. The "new kid on the block": Intraductal papillary mucinous neoplasms of the pancreas: current concepts and controversies. , 2003, Surgery.
[30] G. Klöppel,et al. WHO-classification 2000: exocrine pancreatic tumors. , 2001, Verhandlungen der Deutschen Gesellschaft fur Pathologie.
[31] M. Hollingsworth,et al. Enhancement of metastatic properties of pancreatic cancer cells by MUC1 gene encoding an anti‐adhesion molecule , 2000, International journal of cancer.
[32] L. Aaltonen,et al. Pathology and genetics of tumours of the digestive system , 2000 .
[33] V. Vilgrain,et al. [Intraductal papillary mucinous tumors of the pancreas. Clinical and morphological aspects in 30 patients]. , 1997, Gastroenterologie clinique et biologique.
[34] D. Klimstra,et al. Pancreatic tumors with cystic dilatation of the ducts: intraductal papillary mucinous neoplasms and intraductal oncocytic papillary neoplasms. , 2000, Seminars in diagnostic pathology.
[35] J. Rüschoff,et al. Pancreatic Mucinous Noncystic (Colloid) Carcinomas and Intraductal Papillary Mucinous Carcinomas Are Usually Microsatellite Stable , 2003, Modern Pathology.
[36] A. Gown,et al. CDX2, a Highly Sensitive and Specific Marker of Adenocarcinomas of Intestinal Origin: An Immunohistochemical Survey of 476 Primary and Metastatic Carcinomas , 2003, The American journal of surgical pathology.
[37] L. Yin,et al. The epidermal growth factor receptor regulates interaction of the human DF3/MUC1 carcinoma antigen with c-Src and beta-catenin. , 2001, The Journal of biological chemistry.
[38] K. Batts,et al. Intraductal papillary-mucinous tumors of the pancreas: clinicopathologic features, outcome, and nomenclature. Members of the Pancreas Clinic, and Pancreatic Surgeons of Mayo Clinic. , 1996, Gastroenterology.
[39] E. Paal,et al. A clinicopathologic and immunohistochemical study of 22 intraductal papillary mucinous neoplasms of the pancreas, with a review of the literature. , 1999, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.
[40] Stanley R. Hamilton,et al. Pathology and genetics of tumours of the digestive system , 2000 .
[41] T. Hasebe,et al. Intraductal papillary tumors and mucinous cystic tumors of the pancreas: clinicopathologic study of 38 cases. , 1997, Human pathology.
[42] G. Klöppel. Clinicopathologic view of intraductal papillary-mucinous tumor of the pancreas. , 1998, Hepato-gastroenterology.
[43] T. Tsukamoto,et al. Expression of the intestine-specific transcription factors, Cdx1 and Cdx2, correlates shift to an intestinal phenotype in gastric cancer cells , 2003, Journal of Cancer Research and Clinical Oncology.
[44] D. Klimstra,et al. Intraductal papillary‐mucinous neoplasms of the pancreas , 2002, Cancer.
[45] J. Pearson,et al. The MUC2 gene product: a human intestinal mucin. , 1998, The international journal of biochemistry & cell biology.
[46] K. Sugano,et al. Aberrant expression of CDX2 in Barrett's epithelium and inflammatory esophageal mucosa , 2003, Journal of Gastroenterology.
[47] K. Yamao,et al. Mucin‐producing tumor of the pancreas , 1991, Cancer.
[48] K. Imai,et al. New classification of pancreatic intraductal papillary–mucinous tumour by mucin expression: its relationship with potential for malignancy , 2002, The Journal of pathology.
[49] P. Traber,et al. Cdx1 and cdx2 expression during intestinal development. , 2000, Gastroenterology.
[50] M. Hollingsworth,et al. Expression of MUC1, MUC2, MUC3 and MUC4 mucin mrnas in human pancreatic and intestinal tumor cell lines , 1994, International journal of cancer.
[51] C. Moskaluk,et al. Cdx2 Protein Expression in Normal and Malignant Human Tissues: An Immunohistochemical Survey Using Tissue Microarrays , 2003, Modern Pathology.
[52] Y. Kim,et al. Relationship of pancreatic cancer apomucin to mammary and intestinal apomucins. , 1991, Cancer research.
[53] T. Tsukamoto,et al. Expression of Cdx2 and the phenotype of advanced gastric cancers: relationship with prognosis , 2003, Journal of Cancer Research and Clinical Oncology.
[54] S. Yonezawa,et al. The expression of several types of mucin is related to the biological behavior of pancreatic neoplasms. , 2002, Journal of hepato-biliary-pancreatic surgery.
[55] K. Imai,et al. Effect of MUC1 Mucin, an Anti‐adhesion Molecule, on Tumor Cell Growth , 1996, Japanese journal of cancer research : Gann.
[56] G. Petersen,et al. MUC-2 human small intestinal mucin gene structure. Repeated arrays and polymorphism. , 1991, The Journal of clinical investigation.
[57] M. Tsuneyoshi,et al. Intraductal papillary mucinous neoplasms of the pancreas associated with so-called "mucinous ductal ectasia". Histochemical and immunohistochemical analysis of 29 cases. , 1995, The American journal of surgical pathology.
[58] L. Traverso. Surgical treatment of intraductal papillary mucinous neoplasms of the pancreas: The aggressive approach , 2002, Journal of Gastrointestinal Surgery.
[59] F. Sarkar,et al. Colloid (Mucinous Noncystic) Carcinoma of the Pancreas , 2001, The American journal of surgical pathology.